EKO International Corp  

(Public, OTCMKTS:EKNL)   Watch this stock  
Find more results for EKNL
0.00000 (0.00%)
Apr 29 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.00 - 0.02
Open     -
Vol / Avg. 0.00/10,270.00
Mkt cap 77,623.00
P/E     -
Div/yield     -
EPS -0.01
Shares 31.68M
Beta -3.99
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -18.06% 0.00%
Return on average equity -62.54% 0.00%
Employees 1 -
CDP Score - -


855 Brant Street
+1-289-6441538 (Phone)
+1-302-6528597 (Fax)

Website links


EKO International Corp. is a holding company. The Company is focused on growth through acquisition. The Company, along with NeuroVasc Medical Inc., owns the Frequency Rhythmic Electric Modulation System (FREMS). FREMS equipment is used in the treatment of Peripheral Neuropathy. Peripheral Neuropathy is damage to nerves in extremities, such as lower legs and feet causing an interruption in communication between the brain and parts of the body with damaged nerves. The business of NeuroVasc Clinical Inc. (NCI) is to promote and distribute FREMS equipment supplied by Lorenz Neurovasc Inc.; to set-up and/or manage clinics to treat patients using FREMS equipment, and to set-up training and certification centers for technicians in the use of FREMS equipment.